Literature DB >> 19095132

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

David A Bluemke1, Richard A Kronmal, João A C Lima, Kiang Liu, Jean Olson, Gregory L Burke, Aaron R Folsom.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the relationship of left ventricular (LV) mass and geometry measured with cardiac magnetic resonance imaging (MRI) to incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis) study.
BACKGROUND: MRI is highly accurate for evaluation of heart size and structure and has not previously been used in a large epidemiologic study to predict cardiovascular events.
METHODS: A total of 5,098 participants in the MESA study underwent cardiac MRI at the baseline examination and were followed up for a median of 4 years. Cox proportional hazard models were constructed to predict the end points of coronary heart disease (CHD), stroke, and heart failure (HF) after adjustment for cardiovascular risk factors.
RESULTS: A total of 216 incident events were observed during the follow-up period. In adjusted models, the end points of incident CHD and stroke were positively associated with increased LV mass-to-volume ratio (CHD, hazard ratio [HR]: 2.1 per g/ml, p = 0.02; stroke, HR: 4.2 per g/ml, p = 0.005). In contrast, LV mass showed the strongest association with incident HF events (HR: 1.4 per 10% increment, p < 0.0001). The HF events occurred primarily in participants with LV hypertrophy, that is, >or=95th percentile of LV mass (HR: 8.6, 95% confidence interval: 3.7 to 19.9, reference group <50th percentile of LV mass).
CONCLUSIONS: The LV size was related to incident HF, stroke, and CHD in this multiethnic cohort. Whereas body size-adjusted LV mass alone predicted incident HF, concentric ventricular remodeling predicted incident stroke and CHD.

Entities:  

Mesh:

Year:  2008        PMID: 19095132      PMCID: PMC2706368          DOI: 10.1016/j.jacc.2008.09.014

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  46 in total

Review 1.  Assessment of left ventricular mass by cardiovascular magnetic resonance.

Authors:  Saul G Myerson; Nicholas G Bellenger; Dudley J Pennell
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

2.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

Authors:  N G Bellenger; M I Burgess; S G Ray; A Lahiri; A J Coats; J G Cleland; D J Pennell
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

3.  Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas.

Authors:  Saul G Myerson; Hugh E Montgomery; Michael J World; Dudley J Pennell
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

5.  Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults.

Authors:  M J Roman; T G Pickering; J E Schwartz; R Pini; R B Devereux
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

6.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

Authors:  N G Bellenger; L C Davies; J M Francis; A J Coats; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

7.  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).

Authors:  J M Gardin; R McClelland; D Kitzman; J A Lima; W Bommer; H S Klopfenstein; N D Wong; V E Smith; J Gottdiener
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

8.  Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

Authors:  Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven Snapinn; Hans Wedel
Journal:  JAMA       Date:  2002-09-25       Impact factor: 56.272

9.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  314 in total

1.  Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance.

Authors:  Julio A Chirinos; Patrick Segers; Marc L De Buyzere; Richard A Kronmal; Muhammad W Raja; Dirk De Bacquer; Tom Claessens; Thierry C Gillebert; Martin St John-Sutton; Ernst R Rietzschel
Journal:  Hypertension       Date:  2010-05-10       Impact factor: 10.190

2.  Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study.

Authors:  Steven M Kawut; R Graham Barr; W Craig Johnson; Harjit Chahal; Harikrishna Tandri; Aditya Jain; Michael R Bristow; Jorge R Kizer; Emilia Bagiella; Joao A C Lima; David A Bluemke
Journal:  Biomarkers       Date:  2010-10-05       Impact factor: 2.658

3.  Relationship of left ventricular mass to coronary atherosclerosis and myocardial ischaemia: the CORE320 multicenter study.

Authors:  Satoru Kishi; Tiago A Magalhaes; Richard T George; Marc Dewey; Roger J Laham; Hiroyuki Niinuma; Lisa Aronson Friedman; Christopher Cox; Yutaka Tanami; Joanne D Schuijf; Andrea L Vavere; Kakuya Kitagawa; Marcus Y Chen; Cesar H Nomura; Jeffrey A Brinker; Frank J Rybicki; Marcelo F Di Carli; Armin Arbab-Zadeh; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-11-02       Impact factor: 6.875

4.  Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis).

Authors:  Raymond T Yan; David Bluemke; Antoinette Gomes; Gregory Burke; Steve Shea; Kiang Liu; Hossein Bahrami; Shantanu Sinha; Colin Wu; Veronica Fernandes; Robyn McClelland; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

Review 5.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

6.  Obstructive sleep apnea: the elephant in the cardiovascular room.

Authors:  Jessie P Bakker; Bhavneesh Sharma; Atul Malhotra
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

7.  N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.

Authors:  Eui-Young Choi; Hossein Bahrami; Colin O Wu; Philip Greenland; Mary Cushman; Lori B Daniels; Andre L C Almeida; Kihei Yoneyama; Anders Opdahl; Aditya Jain; Michael H Criqui; David Siscovick; Christine Darwin; Alan Maisel; David A Bluemke; Joao A C Lima
Journal:  Circ Heart Fail       Date:  2012-10-02       Impact factor: 8.790

8.  Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis.

Authors:  Ginger J Winston; Walter Palmas; Joao Lima; Joseph F Polak; Alain G Bertoni; Gregory Burke; John Eng; Rebecca Gottesman; Steven Shea
Journal:  Am J Hypertens       Date:  2013-02-06       Impact factor: 2.689

9.  Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life.

Authors:  Chike C Nwabuo; Yuichiro Yano; Henrique T Moreira; Duke Appiah; Henrique D Vasconcellos; Queen N Aghaji; Anthony Viera; Jamal S Rana; Ravi V Shah; Venkatesh L Murthy; Norrina B Allen; Pamela J Schreiner; Donald M Lloyd-Jones; João A C Lima
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

10.  Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.